HLN

Haleon PLC

Health Care First-pass screen £30.2bn

360/1000 Overall fit

AI beneficiary 35% 25

Operating leverage 25% 42

Valuation 25% 30

Downside protection 15% 60

First-pass take

Haleon is a consumer health CPG company with strong brands and defensive demand, but lacks AI exposure and shows flat operating margins despite 9% organic growth. The elevated 3.6x debt load and missing valuation data preclude deeper analysis against the investment thesis.

Flags

no-valuation-datano-aileverage-3.6xdefensiveflat-margins